Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous bladder cancer, urothelial cancer and genitourinary cancer clinical trials and studies.

Learn more about participating in a clinical trial at Norton Healthcare.

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study

Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Related Stories

First of its kind breast reconstruction surgery available at Norton Healthcare

Program provides comprehensive lung cancer treatment

Oaks Day Is About More Than Pink and Horses

Reconstructing damage from skin cancer